Danaher plans AI-powered autonomous laboratory for antibody research
Danaher said the approach could accelerate the discovery of affinity reagents by up to eight times and increase annual reagent generation by up to tenfold.
Credit: Elpisterra/Shutterstock
The lab, expected to operate at scale in early 2027, will combine AI, robotics and technologies from across Danaher's businesses to accelerate the design and testing of molecular tools.
Register for FREE to keep reading
Join 12,000+ scientists, engineers, and IT professionals driving innovation through informatics, HPC, and simulation with:
- Insights into HPC, AI, lab informatics & data
- Curated content for life sciences, engineering & academia
- Access to Breakthroughs: real-world computing success
- Free reports & panels, including the Lab Informatics Guide
- White Papers & software updates for smarter research
Sign up now
Already a member? Log in here
Your data is protected under our privacy policy.
